Jefferies analyst Akash Tewar reiterated a Buy rating and $42.00 price target on Zymeworks (NASDAQ: ZYME)The analyst commented, "ZYME reported ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE